Breaking News Instant updates and real-time market news.

XLRN

Acceleron

$36.47

-1.14 (-3.03%)

14:34
04/09/18
04/09
14:34
04/09/18
14:34

Acceleron management to meet with Piper Jaffray

Meeting to be held in London on April 9 hosted by Piper Jaffray.

  • 09

    Apr

  • 08

    May

XLRN Acceleron
$36.47

-1.14 (-3.03%)

02/26/18
JPMS
02/26/18
UPGRADE
JPMS
Overweight
Acceleron upgraded to Overweight from Neutral at JPMorgan
02/26/18
JPMS
02/26/18
UPGRADE
Target $52
JPMS
Overweight
JPMorgan upgrades Acceleron to Overweight ahead of luspatercept data
JPMorgan analyst Eric Joseph upgraded Acceleron Pharma to Overweight from Neutral and raised his price target for the shares to $52 from $33 ahead of pivotal data for lead asset luspatercept in myelodysplastic syndrome and beta-thalassemia. The stock closed Friday up 91c to $42.91. The mid-year data readout mark a "potentially transformational catalyst" for Acceleron in transitioning from a development to commercial stage company, Joseph tells investors in a research note. Based on "maturing" Phase 2 datasets and physician feedback, the analyst sees high probabilities of trial success and ultimately approval in each of the indications.
02/28/18
PIPR
02/28/18
NO CHANGE
Target $53
PIPR
Overweight
Acceleron price target raised to $53 from $40 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Acceleron Pharma to $53 and keeps an Overweight rating on the shares following the company's Q4 results. Acceleron ended 2017 with cash of $373M guided to fund the company into 2021, Tenthoff tells investors in a research note.
03/01/18
SBSH
03/01/18
NO CHANGE
Target $63
SBSH
Buy
Acceleron price target raised to $63 from $44 at Citi
Citi analyst Robyn Karnauskas raised her price target for Acceleron Pharma to $63 saying the upcoming luspatercept pivotal data is likely to be positive. The analyst increased her probability of success for luspatercept in beta-thalassemia and ring sideroblast-positive myelodysplastic syndromes to 100% from 80%. She expects positive results from the Phase 3 Medalist and Believe trials when they read out top-line data mid-2018 and keeps a Buy rating on Acceleron.

TODAY'S FREE FLY STORIES

KEG

Key Energy

$8.25

0.02 (0.24%)

06:10
11/20/18
11/20
06:10
11/20/18
06:10
Downgrade
Key Energy rating change  »

Key Energy downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$91.34

-1.95 (-2.09%)

06:09
11/20/18
11/20
06:09
11/20/18
06:09
Hot Stocks
Lowe's sees 'positive trends' in FY19 »

Lowe's CEO Marvin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

STXB

Spirit of Texas Bancshares

$19.23

-0.66 (-3.32%)

06:08
11/20/18
11/20
06:08
11/20/18
06:08
Initiation
Spirit of Texas Bancshares initiated  »

Spirit of Texas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$91.34

-1.95 (-2.09%)

06:07
11/20/18
11/20
06:07
11/20/18
06:07
Hot Stocks
Lowe's to exit Mexico retail operations, exploring strategic alternatives »

Management has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

STKS

One Group Hospitality

$2.77

-0.18 (-6.10%)

06:06
11/20/18
11/20
06:06
11/20/18
06:06
Initiation
One Group Hospitality initiated  »

One Group Hospitality…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

LOW

Lowe's

$91.34

-1.95 (-2.09%)

06:04
11/20/18
11/20
06:04
11/20/18
06:04
Earnings
Lowe's sees FY18 adj. EPS $5.08-$5.13, consensus $5.15 »

Sees FY18 revenue up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

CDNS

Cadence Design

$42.78

-2.98 (-6.51%)

, SNPS

Synopsys

$85.72

-4.37 (-4.85%)

06:04
11/20/18
11/20
06:04
11/20/18
06:04
Initiation
Cadence Design, Synopsys initiated  »

Cadence Design initiated…

CDNS

Cadence Design

$42.78

-2.98 (-6.51%)

SNPS

Synopsys

$85.72

-4.37 (-4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 04

    Dec

  • 05

    Dec

  • 13

    Dec

  • 12

    Mar

KW

Kennedy Wilson

$18.63

-0.2 (-1.06%)

06:03
11/20/18
11/20
06:03
11/20/18
06:03
Hot Stocks
Kennedy Wilson signs two lease deals in Europe with WeWork and ASOS »

Kennedy Wilson has signed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$91.34

-1.95 (-2.09%)

06:02
11/20/18
11/20
06:02
11/20/18
06:02
Earnings
Lowe's reports Q3 adj. EPS $1.04, consensus 98c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

SNPS

Synopsys

$85.72

-4.37 (-4.85%)

06:02
11/20/18
11/20
06:02
11/20/18
06:02
Initiation
Synopsys initiated  »

Synopsys initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 13

    Dec

CYAD

Celyad

$26.97

(0.00%)

06:00
11/20/18
11/20
06:00
11/20/18
06:00
Conference/Events
Celyad management to meet with William Blair »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 22

    Nov

  • 27

    Nov

  • 01

    Dec

  • 03

    Dec

  • 10

    Dec

CSII

Cardiovascular Systems

$28.79

-1.7 (-5.58%)

05:59
11/20/18
11/20
05:59
11/20/18
05:59
Conference/Events
Cardiovascular Systems management to meet with William Blair »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

ACAD

Acadia

$18.14

-0.78 (-4.12%)

, KKR

KKR

$21.08

-0.75 (-3.44%)

05:58
11/20/18
11/20
05:58
11/20/18
05:58
Periodicals
KKR still in talks to buy Acadia Healthcare, NY Post reports »

KKR (KKR) is still deep…

ACAD

Acadia

$18.14

-0.78 (-4.12%)

KKR

KKR

$21.08

-0.75 (-3.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDGL

Madrigal Pharmaceuticals

$120.49

-8.98 (-6.94%)

05:57
11/20/18
11/20
05:57
11/20/18
05:57
Conference/Events
Madrigal Pharmaceuticals management to meet with JMP Securities »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

MCD

McDonald's

$186.69

-0.96 (-0.51%)

05:54
11/20/18
11/20
05:54
11/20/18
05:54
Conference/Events
McDonald's management to meet with MKM Partners »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

KEX

Kirby

$74.67

-1.225 (-1.61%)

05:51
11/20/18
11/20
05:51
11/20/18
05:51
Conference/Events
Kirby management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

EFX

Equifax

$101.75

0.84 (0.83%)

05:50
11/20/18
11/20
05:50
11/20/18
05:50
Periodicals
Equifax to cut 33 jobs from Garden City office, NY Post reports »

Equifax is planning to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

IOVA

Iovance Biotherapeutics

$8.90

-0.68 (-7.10%)

05:47
11/20/18
11/20
05:47
11/20/18
05:47
Conference/Events
Iovance Biotherapeutics management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

FLWS

1-800-Flowers.com

$12.55

-0.2 (-1.57%)

05:45
11/20/18
11/20
05:45
11/20/18
05:45
Conference/Events
1-800-Flowers.com management to meet with Craig Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

BSX

Boston Scientific

$35.29

-1.93 (-5.19%)

05:45
11/20/18
11/20
05:45
11/20/18
05:45
Conference/Events
Boston Scientific to host investor update conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 27

    Nov

DHR

Danaher

$101.29

-1.95 (-1.89%)

05:45
11/20/18
11/20
05:45
11/20/18
05:45
Conference/Events
Danaher management to meet with Morgan Stanley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 30

    Nov

  • 13

    Dec

ARRS

Arris

$30.67

0.01 (0.03%)

05:44
11/20/18
11/20
05:44
11/20/18
05:44
Conference/Events
Arris management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 13

    Dec

COO

Cooper Companies

$256.76

-8.32 (-3.14%)

05:43
11/20/18
11/20
05:43
11/20/18
05:43
Recommendations
Cooper Companies analyst commentary  »

Cooper fundamentals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

  • 06

    Dec

AMP

Ameriprise

$125.95

-0.645 (-0.51%)

05:43
11/20/18
11/20
05:43
11/20/18
05:43
Conference/Events
Ameriprise management to meet with William Blair »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

EPAM

Epam Systems

$120.96

-4.25 (-3.39%)

05:39
11/20/18
11/20
05:39
11/20/18
05:39
Initiation
Epam Systems initiated  »

Epam Systems initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.